trending Market Intelligence /marketintelligence/en/news-insights/trending/qyloykmwtybta-3fwzf1ka2 content esgSubNav
In This List

Endra Life Sciences raises $3.1M through public offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Endra Life Sciences raises $3.1M through public offering

Endra Life Sciences Inc. said it closed a previously announced public offering for gross proceeds of about $3.1 million.

The Ann Arbor, Mich.-based developer of medical imaging technology sold 1,285,000 common shares for $2.10 apiece as part of the offering.

Further, the underwriter fully exercised its over-allotment option to buy an additional 192,750 common shares at the public offering price.

National Securities Corp. acted as sole book-running manager for the offering.